Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Julve

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Current Vascular Pharmacology|December 15, 2010
Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosisJosep Julve, Gemma Llaverias, Francisco Blanco-Vaca, et al.
Atherosclerosis|April 14, 2009
In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotectionJoan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, et al.
Revista De Neurologia|March 4, 2010
[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]Jesús Méndez-González, Elisabeth Rodríguez-Millán, Josep Julve, et al.
Current Atherosclerosis Reports|April 29, 2021
Reverse Cholesterol Transport Dysfunction Is a Feature of Familial HypercholesterolemiaJoan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, et al.
International Journal of Molecular Sciences|October 27, 2022
Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated AtherosclerosisRaquel Griñán, Joan Carles Escolà-Gil, Josep Julve, et al.
Nutrients|August 27, 2021
Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal StudiesBianca Papotti, Joan Carles Escolà-Gil, Josep Julve, et al.
Journal of Clinical Medicine|December 30, 2025
Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old DiseaseJosep Julve, Ricardo Rodriguez-Calvo, Bertrand Perret, et al.
Cardiovascular Diabetology|February 12, 2024
The double burden: type 1 diabetes and heart failure-a comprehensive reviewMaría Teresa Julián, Alejandra Pérez-Montes de Oca, Josep Julve, et al.
Cardiovascular Research|January 11, 2005
Human adipose tissue as a source of Flk-1+ cells: new method of differentiation and expansionOfelia María Martínez-Estrada, Yolanda Muñoz-Santos, Josep Julve, et al.
Journal of Clinical Lipidology|September 25, 2017
A novel homozygous mutation causing lecithin-cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemiaDavid Rial-Crestelo, Ildefonso Santos-Recuero, Josep Julve, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Current Vascular Pharmacology|December 15, 2010
Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosisJosep Julve, Gemma Llaverias, Francisco Blanco-Vaca, et al.
Atherosclerosis|April 14, 2009
In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotectionJoan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, et al.
Revista De Neurologia|March 4, 2010
[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]Jesús Méndez-González, Elisabeth Rodríguez-Millán, Josep Julve, et al.
Current Atherosclerosis Reports|April 29, 2021
Reverse Cholesterol Transport Dysfunction Is a Feature of Familial HypercholesterolemiaJoan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, et al.
International Journal of Molecular Sciences|October 27, 2022
Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated AtherosclerosisRaquel Griñán, Joan Carles Escolà-Gil, Josep Julve, et al.
Nutrients|August 27, 2021
Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal StudiesBianca Papotti, Joan Carles Escolà-Gil, Josep Julve, et al.
Journal of Clinical Medicine|December 30, 2025
Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old DiseaseJosep Julve, Ricardo Rodriguez-Calvo, Bertrand Perret, et al.
Cardiovascular Diabetology|February 12, 2024
The double burden: type 1 diabetes and heart failure-a comprehensive reviewMaría Teresa Julián, Alejandra Pérez-Montes de Oca, Josep Julve, et al.
Cardiovascular Research|January 11, 2005
Human adipose tissue as a source of Flk-1+ cells: new method of differentiation and expansionOfelia María Martínez-Estrada, Yolanda Muñoz-Santos, Josep Julve, et al.
Journal of Clinical Lipidology|September 25, 2017
A novel homozygous mutation causing lecithin-cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemiaDavid Rial-Crestelo, Ildefonso Santos-Recuero, Josep Julve, et al.
Pageof 13